March 10, 2022
Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
Domain Therapeutics, a biopharmaceutical company specializing in the discovery and development of new drugs targeting G Protein-Coupled Receptors (GPCRs) in…